Aclaris Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $73k | 70k | 1.05 |
| 2023-09-30 | $2.7M | 400k | 6.85 |
| 2023-06-30 | $4.4M | 427k | 10.37 |
| 2023-03-31 | $3.1M | 355k | 8.71 |
| 2022-12-31 | $6.7M | 428k | 15.75 |
| 2022-06-30 | $6.4M | 462k | 13.96 |
| 2022-03-31 | $771k | 45k | 17.27 |
| 2021-12-31 | $541k | 37k | 14.54 |
| 2021-03-31 | $999 | 21 | 47.62 |
| 2020-12-31 | $0 | 37 | 0.00 |
| 2020-09-30 | $0 | 37 | 0.00 |
| 2020-06-30 | $0 | 37 | 0.00 |
| 2020-03-31 | $0 | 179k | 0.00 |
| 2019-12-31 | $388k | 206k | 1.89 |
| 2019-09-30 | $234k | 216k | 1.08 |
| 2019-06-30 | $870k | 408k | 2.13 |
| 2019-03-31 | $1.4M | 246k | 5.65 |
| 2018-12-31 | $1.4M | 194k | 7.39 |
| 2018-09-30 | $2.7M | 188k | 14.52 |
| 2018-06-30 | $3.7M | 184k | 19.97 |
| 2018-03-31 | $3.3M | 190k | 17.52 |
| 2017-12-31 | $124k | 5.0k | 24.73 |
| 2016-12-31 | $207k | 7.6k | 27.17 |